ATE527997T1 - Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien - Google Patents
Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathienInfo
- Publication number
- ATE527997T1 ATE527997T1 AT07734240T AT07734240T ATE527997T1 AT E527997 T1 ATE527997 T1 AT E527997T1 AT 07734240 T AT07734240 T AT 07734240T AT 07734240 T AT07734240 T AT 07734240T AT E527997 T1 ATE527997 T1 AT E527997T1
- Authority
- AT
- Austria
- Prior art keywords
- aminapthone
- arteriopathies
- medication
- treatment
- production
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title 1
- YLMPBJUYFTWHKJ-UHFFFAOYSA-N aminaphthone Chemical compound CC1=C(O)C2=CC=CC=C2C(O)=C1OC(=O)C1=CC=C(N)C=C1 YLMPBJUYFTWHKJ-UHFFFAOYSA-N 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000712A ITMI20060712A1 (it) | 2006-04-11 | 2006-04-11 | Uso di aminaftone per la preparazione di un medicamento per il trattamento delle arteriopatie |
| PCT/IB2007/000921 WO2007116297A2 (en) | 2006-04-11 | 2007-04-10 | Use of aminapthone for the preparation of a medicament for treating arteriophaties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE527997T1 true ATE527997T1 (de) | 2011-10-15 |
Family
ID=38480588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07734240T ATE527997T1 (de) | 2006-04-11 | 2007-04-10 | Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8202903B2 (de) |
| EP (2) | EP2335695B1 (de) |
| JP (1) | JP2009533414A (de) |
| AT (1) | ATE527997T1 (de) |
| CA (1) | CA2648751C (de) |
| ES (2) | ES2374659T3 (de) |
| IT (1) | ITMI20060712A1 (de) |
| PT (2) | PT2004173E (de) |
| WO (1) | WO2007116297A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1400389B1 (it) * | 2010-05-27 | 2013-05-31 | Baldacci Lab Spa | Aminaftone per uso nel trattamento e/o nella prevenzione dell'emicrania |
| US9753909B2 (en) | 2012-09-07 | 2017-09-05 | Splunk, Inc. | Advanced field extractor with multiple positive examples |
| US9152929B2 (en) | 2013-01-23 | 2015-10-06 | Splunk Inc. | Real time display of statistics and values for selected regular expressions |
| IT201900006572A1 (it) * | 2019-05-06 | 2020-11-06 | Laboratori Baldacci Spa | Nuovo metodo di analisi hplc dell'aminaftone |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT252224B (de) * | 1964-10-05 | 1967-02-10 | Finanz Kompensations Anst | Verfahren zur Herstellung von neuen 2-Aminobenzoyloxy-naphthohydrochinonen |
| ES456574A1 (es) | 1977-03-07 | 1978-02-16 | Rocador Sa | Procedimiento de obtencion de pentametil-carbamato de quer- cetina. |
| IT1201149B (it) | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche |
| US5648377A (en) | 1993-12-21 | 1997-07-15 | Indena S.P.A. | Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
| IT1275955B1 (it) | 1995-03-22 | 1997-10-24 | Dompe Spa | Formulazioni farmaceutiche in forma di gel tissotropico |
| ATE322904T1 (de) | 2000-05-25 | 2006-04-15 | Boehringer Ingelheim Int | Zusammensetzung zum verbesserten zellenschutz welche ein lipophiles antioxydans sowie ein hydrophilen antioxidans enthält |
| JP2003238439A (ja) * | 2002-02-13 | 2003-08-27 | Yasuhiko Tabata | 虚血治療剤 |
| WO2003094917A1 (en) * | 2002-05-13 | 2003-11-20 | Takata Seiyaku Co., Ltd. | Vintoperol-containing medicinal composition for transdermal administration |
| US7202222B2 (en) | 2003-01-06 | 2007-04-10 | National Bioscience Corporation | Methods for treatment of obesity and effective fat loss promotion |
| JP4598593B2 (ja) * | 2004-05-10 | 2010-12-15 | 晶岩 韓 | 虚血再灌流による微小循環障害の予防・治療用薬剤 |
-
2006
- 2006-04-11 IT IT000712A patent/ITMI20060712A1/it unknown
-
2007
- 2007-04-10 WO PCT/IB2007/000921 patent/WO2007116297A2/en not_active Ceased
- 2007-04-10 PT PT07734240T patent/PT2004173E/pt unknown
- 2007-04-10 AT AT07734240T patent/ATE527997T1/de active
- 2007-04-10 EP EP11153882.3A patent/EP2335695B1/de active Active
- 2007-04-10 PT PT111538823T patent/PT2335695E/pt unknown
- 2007-04-10 ES ES07734240T patent/ES2374659T3/es active Active
- 2007-04-10 US US12/296,872 patent/US8202903B2/en active Active
- 2007-04-10 JP JP2009504844A patent/JP2009533414A/ja active Pending
- 2007-04-10 ES ES11153882.3T patent/ES2519345T3/es active Active
- 2007-04-10 CA CA2648751A patent/CA2648751C/en active Active
- 2007-04-10 EP EP07734240A patent/EP2004173B1/de active Active
-
2011
- 2011-01-13 US US13/005,902 patent/US10028929B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2004173A2 (de) | 2008-12-24 |
| US8202903B2 (en) | 2012-06-19 |
| CA2648751A1 (en) | 2007-10-18 |
| US20120022155A1 (en) | 2012-01-26 |
| ITMI20060712A1 (it) | 2007-10-12 |
| EP2335695A1 (de) | 2011-06-22 |
| PT2335695E (pt) | 2014-10-29 |
| CA2648751C (en) | 2013-01-22 |
| US10028929B2 (en) | 2018-07-24 |
| EP2004173B1 (de) | 2011-10-12 |
| WO2007116297A3 (en) | 2008-01-10 |
| ES2519345T3 (es) | 2014-11-06 |
| ES2374659T3 (es) | 2012-02-20 |
| WO2007116297A2 (en) | 2007-10-18 |
| EP2335695B1 (de) | 2014-08-20 |
| BRPI0711841A2 (pt) | 2011-12-13 |
| JP2009533414A (ja) | 2009-09-17 |
| US20090182045A1 (en) | 2009-07-16 |
| PT2004173E (pt) | 2012-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010005631A (es) | Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades. | |
| MX2008014101A (es) | Acidos carboxilicos sustituidos con 4,5-difenil-pirimidinilamino, metodo para su produccion y su uso como medicamentos. | |
| CY1111454T1 (el) | Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων | |
| EA200801580A1 (ru) | Новые производные пирониндола и способ их получения | |
| IL188176A0 (en) | Stable pharmaceutical composition comprising linezolid form iv | |
| CY1115725T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων | |
| ATE548032T1 (de) | Verwendung von chlorguanabenzderivaten zur behandlung von mit polyglutaminexpansion assoziierten erkrankungen | |
| CY1114760T1 (el) | Θεραπευτικη αγωγη αθηροσκληρωσης | |
| ATE526015T1 (de) | Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien | |
| TW200604196A (en) | New quinuclidine derivatives and pharmaceutical compositions comprising them | |
| EA200900269A1 (ru) | Лекарственные комбинации для лечения заболеваний дыхательных путей | |
| ATE524488T1 (de) | Lysobactinamide | |
| ATE444754T1 (de) | Verwendung von tyrosinkinase-inhibitoren zur behandlung inflammatorischer prozesse | |
| UA96951C2 (ru) | ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЯ КАК ЛЕКАРСТВЕННЫХ СРЕДСТВ | |
| ATE424195T1 (de) | Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen | |
| MY146802A (en) | Novel drugs for treating respiratory diseases | |
| CY1110156T1 (el) | Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης | |
| EP2216043A4 (de) | Verwendung von induktormitteln gse24.2 zur herstellung pharmazeutischer zusammensetzungen zur behandlung von erkrankungen in zusammenhang mit zellseneszenz | |
| ATE477820T1 (de) | Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten | |
| ATE455789T1 (de) | Substituierte nonadepsipeptide | |
| ATE479423T1 (de) | Vorrichtung für die topische anwendung des medizinischen ozons zur behandlung von erkrankungen der mundhöhle | |
| ATE504301T1 (de) | Verwendung von natriumblockern zur frühzeitigen behandlung von obstruktiven lungenerkrankungen | |
| ITMI20060712A1 (it) | Uso di aminaftone per la preparazione di un medicamento per il trattamento delle arteriopatie | |
| ATE491443T1 (de) | Verwendung des agomelatins zur herstellung eines medikamentes zur behandlung der bipolaren erkrankungen | |
| ATE391710T1 (de) | Substituierte azetidinverbindungen als cyclooxigenase-1-cyclooxygenase-2-inhibitoren und deren herstellung und verwendung als medikament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2004173 Country of ref document: EP |